Will Bristol-Myers Squibb’s I-O (Opdivo+Yervoy) -ongoing CheckMate 743 study meet the unmet need for untreated malignant pleural mesothelioma (MPM)?
Malignant pleural mesothelioma (MPM) is a relatively rare but aggressive form of cancer arising from the membrane covering the lungs and the inner side of the ribs. This type of cancer is most frequently a […]